MedTrace Logo

Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing

NCT03497325 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2021-07-21

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of intramuscular autologus platelet rich plasma on uterine wound healing after primary cesarean section

Conditions

  • Cesarean Section Complications

Interventions

DRUG

autologus platelet rich plasma

55 participant unergoing prelabor primary CS will receive intramyometrial injection of PRP after closure of uterine incision

DRUG

placebo

55 participant unergoing prelabor primary CS will receive intramyometrial injection of normal saline after closure of uterine incision

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-12-15
Completion
2020-12-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03497325 on ClinicalTrials.gov